Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor - PubMed (original) (raw)
. 2000 Dec 15;352 Pt 3(Pt 3):739-45.
Affiliations
- PMID: 11104681
- PMCID: PMC1221512
Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor
G Vitale et al. Biochem J. 2000.
Abstract
The lethal factor (LF) produced by toxigenic strains of Bacillus anthracis is a Zn(2+)-endopeptidase that cleaves the mitogen-activated protein kinase kinases (MAPKKs) MEK1, MEK2 and MKK3. Using genetic and biochemical approaches, we have extended the study of LF proteolytic specificity to all known MAPKK family members and found that LF also cleaves MKK4, MKK6 and MKK7, but not MEK5. The peptide bonds hydrolysed by LF within all MAPKKs were identified. Cleavage invariably occurs within the N-terminal proline-rich region preceding the kinase domain, thus disrupting a sequence involved in directing specific protein-protein interactions necessary for the assembly of signalling complexes. Alignment of the sequences flanking the site of cleavage reveals the occurrence of some consensus motifs: position P2 and P1' are occupied by hydrophobic residues and at least one basic residue is present between P4 and P7. The implications of these findings for the biochemical activity and functional specificity of LF are discussed.
Similar articles
- Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs.
Bardwell AJ, Abdollahi M, Bardwell L. Bardwell AJ, et al. Biochem J. 2004 Mar 1;378(Pt 2):569-77. doi: 10.1042/BJ20031382. Biochem J. 2004. PMID: 14616089 Free PMC article. - Identification of a Substrate-selective Exosite within the Metalloproteinase Anthrax Lethal Factor.
Goldberg AB, Cho E, Miller CJ, Lou HJ, Turk BE. Goldberg AB, et al. J Biol Chem. 2017 Jan 20;292(3):814-825. doi: 10.1074/jbc.M116.761734. Epub 2016 Dec 1. J Biol Chem. 2017. PMID: 27909054 Free PMC article. - Crystal structure of the anthrax lethal factor.
Pannifer AD, Wong TY, Schwarzenbacher R, Renatus M, Petosa C, Bienkowska J, Lacy DB, Collier RJ, Park S, Leppla SH, Hanna P, Liddington RC. Pannifer AD, et al. Nature. 2001 Nov 8;414(6860):229-33. doi: 10.1038/n35101998. Nature. 2001. PMID: 11700563 - Anthrax, MEK and cancer.
Bodart JF, Chopra A, Liang X, Duesbery N. Bodart JF, et al. Cell Cycle. 2002 Jan;1(1):10-5. Cell Cycle. 2002. PMID: 12429903 Review. - The anthrax lethal factor and its MAPK kinase-specific metalloprotease activity.
Tonello F, Montecucco C. Tonello F, et al. Mol Aspects Med. 2009 Dec;30(6):431-8. doi: 10.1016/j.mam.2009.07.006. Epub 2009 Aug 7. Mol Aspects Med. 2009. PMID: 19665472 Review.
Cited by
- Visualization of immune pathways that enhance the neutralizing antibody response to vaccines after primary immunization.
Verma A, De Pascalis R, Mocca CP, Li X, Burns DL. Verma A, et al. mBio. 2024 Mar 13;15(3):e0003724. doi: 10.1128/mbio.00037-24. Epub 2024 Feb 9. mBio. 2024. PMID: 38334423 Free PMC article. - The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes.
Maier NK, Leppla SH, Moayeri M. Maier NK, et al. J Immunol. 2015 Mar 15;194(6):2776-85. doi: 10.4049/jimmunol.1401611. Epub 2015 Feb 13. J Immunol. 2015. PMID: 25681332 Free PMC article. - Gold nanoparticles-based protease assay.
Guarise C, Pasquato L, De Filippis V, Scrimin P. Guarise C, et al. Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):3978-82. doi: 10.1073/pnas.0509372103. Epub 2006 Mar 1. Proc Natl Acad Sci U S A. 2006. PMID: 16537471 Free PMC article. - Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains.
Drysdale M, Olson G, Koehler TM, Lipscomb MF, Lyons CR. Drysdale M, et al. Infect Immun. 2007 Apr;75(4):1757-64. doi: 10.1128/IAI.01712-06. Epub 2007 Jan 22. Infect Immun. 2007. PMID: 17242059 Free PMC article. - Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo.
Pini A, Runci Y, Falciani C, Lelli B, Brunetti J, Pileri S, Fabbrini M, Lozzi L, Ricci C, Bernini A, Tonello F, Dal Molin F, Neri P, Niccolai N, Bracci L. Pini A, et al. Biochem J. 2006 Apr 1;395(1):157-63. doi: 10.1042/BJ20051747. Biochem J. 2006. PMID: 16398644 Free PMC article.
References
- Biochem J. 1996 Dec 1;320 ( Pt 2):687-91 - PubMed
- J Biol Chem. 1996 Oct 25;271(43):26981-8 - PubMed
- Cell Signal. 1997 Sep;9(6):403-10 - PubMed
- Science. 1998 May 1;280(5364):734-7 - PubMed
- Infect Immun. 1998 May;66(5):2374-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous